Exact Mass: 339.1794

Exact Mass Matches: 339.1794

Found 74 metabolites which its exact mass value is equals to given mass value 339.1794, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nalmefene

NALMEFENE-HCl

C21H25NO3 (339.1834)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Perazine

10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine

C20H25N3S (339.1769)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

Xamoterol

Xamoterol hemifumarate

C16H25N3O5 (339.1794)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Same as: D06328

   

NCIOpen2_009010

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

C21H25NO3 (339.1834)


   

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.1834)


Dehydropipernonaline is found in herbs and spices. Dehydropipernonaline is isolated from fruits of Piper longum (long pepper). Isolated from fruits of Piper longum (long pepper). Dehydropipernonaline is found in herbs and spices and pepper (spice).

   

7-[(4-Fluorophenyl)methoxy]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]pyrrolo[2,3-d]pyridazine

7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]-1H-pyrrolo[2,3-d]pyridazine

C20H22FN3O (339.1747)


   

Alogliptin

2-{[6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]methyl}benzonitrile

C18H21N5O2 (339.1695)


   

Edivoxetine

(R)-2-(5-Fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethanol

C18H26FNO4 (339.1846)


   

Nalmefene

4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol

C21H25NO3 (339.1834)


   

2-Dehydrodeacetylheterophylloidine

2-Dehydrodeacetylheterophylloidine

C21H25NO3 (339.1834)


   
   
   

2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one

2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one

C21H25NO3 (339.1834)


   

malbranpyrrole A

malbranpyrrole A

C21H25NO3 (339.1834)


   

n,n-dimethyl-2-(2,3,4-trimethoxyphenanthren-1-yl)ethanamine

n,n-dimethyl-2-(2,3,4-trimethoxyphenanthren-1-yl)ethanamine

C21H25NO3 (339.1834)


   

Dextromoramide M4

Dextromoramide M4

C21H25NO3 (339.1834)


   
   
   

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.1834)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(3-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(3-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

C17H26ClN3O2 (339.1713)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(4-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(4-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE

C17H26ClN3O2 (339.1713)


   

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

C21H25NO3 (339.1834)


   

C-(1-TRITYL-1H-IMIDAZOL-4-YL)-METHYLAMINE

C-(1-TRITYL-1H-IMIDAZOL-4-YL)-METHYLAMINE

C23H21N3 (339.1735)


   

Piperilate

2-piperidin-1-ylethyl 2-hydroxy-2,2-diphenylacetate

C21H25NO3 (339.1834)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

C18H27ClFN3 (339.1877)


   

2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)-3H-PYRROLO[2,3-D]PYRIMIDIN-4(7H)-ONE

2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)-3H-PYRROLO[2,3-D]PYRIMIDIN-4(7H)-ONE

C18H21N5O2 (339.1695)


   

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794)


   

Alogliptin

Alogliptin

C18H21N5O2 (339.1695)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

2-[4-(3-phenylquinoxalin-2-yl)phenyl]propan-2-amine

2-[4-(3-phenylquinoxalin-2-yl)phenyl]propan-2-amine

C23H21N3 (339.1735)


   

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

C21H25NO3 (339.1834)


   

azanium,cumene,furan-2,5-dione,styrene

azanium,cumene,furan-2,5-dione,styrene

C21H25NO3+ (339.1834)


   

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794)


   

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)MORPHOLINE HYDROCHLORIDE

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)MORPHOLINE HYDROCHLORIDE

C17H27BClNO3 (339.1772)


   

2-butyl-6-methyl-3-(4-nitrobenzyl)-3H-imidazo[4,5-b]pyridin-5-amine

2-butyl-6-methyl-3-(4-nitrobenzyl)-3H-imidazo[4,5-b]pyridin-5-amine

C18H21N5O2 (339.1695)


   

2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile

2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile

C18H21N5O2 (339.1695)


   
   

3-(4-MORPHOLINOMETHYL)-PHENYLBORONIC ACID PINACOL ESTER HYDROCHLORIDE

3-(4-MORPHOLINOMETHYL)-PHENYLBORONIC ACID PINACOL ESTER HYDROCHLORIDE

C17H27BClNO3 (339.1772)


   

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

C21H25NO3 (339.1834)


   

6-(fmoc-amino)-1-hexanol

6-(fmoc-amino)-1-hexanol

C21H25NO3 (339.1834)


   
   

ORG-25935 free base

ORG-25935 free base

C21H25NO3 (339.1834)


   

Edivoxetine

Edivoxetine

C18H26FNO4 (339.1846)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

2,4-Diamino-6-[N-(2,5-dimethoxybenzyl)-N-methylamino]quinazoline

2,4-Diamino-6-[N-(2,5-dimethoxybenzyl)-N-methylamino]quinazoline

C18H21N5O2 (339.1695)


   

Piroheptine hydrochloride

Piroheptine hydrochloride

C22H26ClN (339.1754)


   

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

C21H25NO3 (339.1834)


   

6-Cyclohexylmethyloxy-2-(4-hydroxyanilino)purine

6-Cyclohexylmethyloxy-2-(4-hydroxyanilino)purine

C18H21N5O2 (339.1695)


   

(3r,4r)-4-(Pyrrolidin-1-Ylcarbonyl)-1-(Quinoxalin-2-Ylcarbonyl)pyrrolidin-3-Amine

(3r,4r)-4-(Pyrrolidin-1-Ylcarbonyl)-1-(Quinoxalin-2-Ylcarbonyl)pyrrolidin-3-Amine

C18H21N5O2 (339.1695)


   

4-benzyl-N-(2,4-dimethylphenyl)piperazine-1-carbothioamide

4-benzyl-N-(2,4-dimethylphenyl)piperazine-1-carbothioamide

C20H25N3S (339.1769)


   

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

C21H25NO3 (339.1834)


   

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

C21H25NO3 (339.1834)


   

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

C21H25NO3 (339.1834)


   

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

C21H25NO3 (339.1834)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

PF-670462 free base(2+)

PF-670462 free base(2+)

C19H22FN5+2 (339.1859)


   
   

PERAZINE

PERAZINE

C20H25N3S (339.1769)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

C21H25NO3 (339.1834)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

perivine(1+)

perivine(1+)

C20H23N2O3 (339.1709)


A secondary ammonium ion that is the conjugate acid of perivine obtained by protonation of the secondary amino group; major species at pH 7.3.

   

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

C21H25NO3 (339.1834)


   

2-methoxy-5-methyl-6-[(1e,3e)-3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

2-methoxy-5-methyl-6-[(1e,3e)-3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

C21H25NO3 (339.1834)


   

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.1834)


   

(6r,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

(6r,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.1834)


   

(1s,5r,8r,9s,11r,14s,17s,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

(1s,5r,8r,9s,11r,14s,17s,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

C21H25NO3 (339.1834)


   

1-[(2r)-2-hydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-2,9-dihydro-1h-carbazole-3,4-dione

1-[(2r)-2-hydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-2,9-dihydro-1h-carbazole-3,4-dione

C21H25NO3 (339.1834)


   

(6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

(6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.1834)


   

dimethyl[2-(3,4,8-trimethoxyphenanthren-1-yl)ethyl]amine

dimethyl[2-(3,4,8-trimethoxyphenanthren-1-yl)ethyl]amine

C21H25NO3 (339.1834)


   

4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.1834)


   

(2e,4z,8e)-9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

(2e,4z,8e)-9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.1834)


   

(1r,5r,8r,9s,11s,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

(1r,5r,8r,9s,11s,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

C21H25NO3 (339.1834)


   

2-methoxy-5-methyl-6-[3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

2-methoxy-5-methyl-6-[3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

C21H25NO3 (339.1834)


   

dimethyl[2-(2,3,4-trimethoxyphenanthren-1-yl)ethyl]amine

dimethyl[2-(2,3,4-trimethoxyphenanthren-1-yl)ethyl]amine

C21H25NO3 (339.1834)


   

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

C21H25NO3 (339.1834)


   

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

C21H25NO3 (339.1834)


   

(4s,5r,8r,9s,10s)-3-hydroxy-5,9-dimethyl-14-oxa-7-azahexacyclo[15.2.1.1⁷,¹⁰.0⁴,⁸.0⁹,¹⁹.0¹³,¹⁸]henicosa-1(19),13(18),17(20)-trien-2-one

(4s,5r,8r,9s,10s)-3-hydroxy-5,9-dimethyl-14-oxa-7-azahexacyclo[15.2.1.1⁷,¹⁰.0⁴,⁸.0⁹,¹⁹.0¹³,¹⁸]henicosa-1(19),13(18),17(20)-trien-2-one

C21H25NO3 (339.1834)


   

(6s,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

(6s,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.1834)